BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shuai Z, Leung MW, He X, Zhang W, Yang G, Leung PS, Eric Gershwin M. Adaptive immunity in the liver. Cell Mol Immunol 2016;13:354-68. [PMID: 26996069 DOI: 10.1038/cmi.2016.4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Tian Z. NK cell subsets in autoimmune diseases. Journal of Autoimmunity 2017;83:22-30. [DOI: 10.1016/j.jaut.2017.02.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
2 Liu M, Zhang C. The Role of Innate Lymphoid Cells in Immune-Mediated Liver Diseases. Front Immunol 2017;8:695. [PMID: 28659927 DOI: 10.3389/fimmu.2017.00695] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
3 Sun C, Lan P, Han Q, Huang M, Zhang Z, Xu G, Song J, Wang J, Wei H, Zhang J, Sun R, Zhang C, Tian Z. Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. Nat Commun 2018;9:1241. [PMID: 29593314 DOI: 10.1038/s41467-018-03584-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 8.5] [Reference Citation Analysis]
4 Cheng X, Yu P, Zhou X, Zhu J, Han Y, Zhang C, Kong L. Enhanced tumor homing of pathogen-mimicking liposomes driven by R848 stimulation: A new platform for synergistic oncology therapy. Acta Pharmaceutica Sinica B 2021. [DOI: 10.1016/j.apsb.2021.08.018] [Reference Citation Analysis]
5 Guo M, Li C. An overview of cytokine used as adjuvants in fish: current state and future trends. Rev Aquacult 2021;13:996-1014. [DOI: 10.1111/raq.12509] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zevin AS, Moats C, May D, Wangari S, Miller C, Ahrens J, Iwayama N, Brown M, Bratt D, Klatt NR, Smedley J. Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques. J Vis Exp 2017. [PMID: 28518089 DOI: 10.3791/55617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Fickert P, Wagner M. Biliary bile acids in hepatobiliary injury - What is the link? J Hepatol. 2017;67:619-631. [PMID: 28712691 DOI: 10.1016/j.jhep.2017.04.026] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 14.4] [Reference Citation Analysis]
8 Fang F, Xiao W, Tian Z. NK cell-based immunotherapy for cancer. Seminars in Immunology 2017;31:37-54. [DOI: 10.1016/j.smim.2017.07.009] [Cited by in Crossref: 125] [Cited by in F6Publishing: 124] [Article Influence: 25.0] [Reference Citation Analysis]
9 Sun H, Sun C, Xiao W, Sun R. Tissue-resident lymphocytes: from adaptive to innate immunity. Cell Mol Immunol 2019;16:205-15. [PMID: 30635650 DOI: 10.1038/s41423-018-0192-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
10 Zhang W, Zhang R, Zhang J, Sun Y, Leung PS, Yang GX, Shuai Z, Ridgway WM, Gershwin ME. Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis. Cell Mol Immunol 2018;15:756-67. [PMID: 29375127 DOI: 10.1038/cmi.2017.149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Crawford JM, Bioulac-sage P, Hytiroglou P. Structure, Function, and Responses to Injury. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 1-87. [DOI: 10.1016/b978-0-7020-6697-9.00001-7] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Mulaikal TA, Emond JC. Physiology and Anatomy of the Liver. In: Wagener G, editor. Liver Anesthesiology and Critical Care Medicine. Cham: Springer International Publishing; 2018. pp. 3-19. [DOI: 10.1007/978-3-319-64298-7_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Ray JL, Kopec AK, Joshi N, Cline-Fedewa H, Lash LH, Williams KJ, Leung PS, Gershwin ME, Luyendyk JP. Trichloroethylene Exposure Reduces Liver Injury in a Mouse Model of Primary Biliary Cholangitis. Toxicol Sci 2017;156:428-37. [PMID: 28115651 DOI: 10.1093/toxsci/kfw264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zheng M, Sun H, Tian Z. Natural killer cells in liver diseases. Front Med 2018;12:269-79. [PMID: 29675689 DOI: 10.1007/s11684-018-0621-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 Yu J, Chen Y, Wu Y, Ye L, Lian Z, Wei H, Sun R, Tian Z. The differential organogenesis and functionality of two liver-draining lymph nodes in mice. J Autoimmun 2017;84:109-21. [PMID: 28886898 DOI: 10.1016/j.jaut.2017.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
16 Zong L, Peng H, Sun C, Li F, Zheng M, Chen Y, Wei H, Sun R, Tian Z. Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice. Nat Commun. 2019;10:221. [PMID: 30644386 DOI: 10.1038/s41467-018-08096-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
17 Liu W, Zeng X, Liu Y, Liu J, Li C, Chen L, Chen H, Ouyang D. The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury. Front Pharmacol 2021;12:723940. [PMID: 34721020 DOI: 10.3389/fphar.2021.723940] [Reference Citation Analysis]
18 Li N, Hua J. Immune cells in liver regeneration. Oncotarget. 2017;8:3628-3639. [PMID: 27690296 DOI: 10.18632/oncotarget.12275] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
19 Zhang Q, Yu X, Zheng Q, He Y, Guo W. A Molecular Subtype Model for Liver HBV-Related Hepatocellular Carcinoma Patients Based on Immune-Related Genes. Front Oncol 2020;10:560229. [PMID: 33072587 DOI: 10.3389/fonc.2020.560229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Bellanti F, Pannone G, Tartaglia N, Serviddio G. Redox Control of the Immune Response in the Hepatic Progenitor Cell Niche. Front Cell Dev Biol 2020;8:295. [PMID: 32435643 DOI: 10.3389/fcell.2020.00295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Hoan NX, Huyen PTM, Binh MT, Trung NT, Giang DP, Linh BT, Dung DTN, Pallerla SR, Kremsner PG, Velavan TP, Bang MH, Song LH. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression. Sci Rep 2021;11:7772. [PMID: 33833369 DOI: 10.1038/s41598-021-87537-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Zahran AM, Nafady-Hego H, Mansor SG, Abbas WA, Abdel-Malek MO, Mekky MA, Hetta HF. Increased frequency and FOXP3 expression of human CD8+CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma. Hum Immunol 2019;80:510-6. [PMID: 30904437 DOI: 10.1016/j.humimm.2019.03.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
23 Sun H, Huang Q, Huang M, Wen H, Lin R, Zheng M, Qu K, Li K, Wei H, Xiao W, Sun R, Tian Z, Sun C. Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma. Hepatology. 2019;70:168-183. [PMID: 30411378 DOI: 10.1002/hep.30347] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 26.0] [Reference Citation Analysis]
24 Liu L, Dai B, Li R, Liu Z, Zhang Z. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics 2021;11:194-208. [PMID: 33391470 DOI: 10.7150/thno.44979] [Reference Citation Analysis]
25 Wang Z, Zhang S. Multi-omic analyses of hepatocellular carcinoma to determine immunological characteristics and key nodes in gene-expression network. Biosci Rep 2021;41:BSR20211241. [PMID: 34212175 DOI: 10.1042/BSR20211241] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Fickert P. Bad memories from the gut may cause nightmares for the bile ducts. J Hepatol 2017;66:5-7. [PMID: 27702642 DOI: 10.1016/j.jhep.2016.09.016] [Reference Citation Analysis]
27 Dai K, Huang L, Huang YB, Chen ZB, Yang LH, Jiang YA. 1810011o10 Rik Inhibits the Antitumor Effect of Intratumoral CD8+ T Cells through Suppression of Notch2 Pathway in a Murine Hepatocellular Carcinoma Model. Front Immunol 2017;8:320. [PMID: 28382040 DOI: 10.3389/fimmu.2017.00320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
28 Zheng C, Yin S, Yang Y, Yu Y, Xie X. CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-γ production by CD4+ T cells. Cell Mol Immunol 2018;15:260-71. [PMID: 28065940 DOI: 10.1038/cmi.2016.57] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
29 Jayant K, Habib N, Huang KW, Warwick J, Arasaradnam R. Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma. Diagnostics (Basel). 2020;10. [PMID: 32466214 DOI: 10.3390/diagnostics10050338] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Bessone F, Hernández N, Tanno M, Roma MG. Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics. Semin Liver Dis 2021;41:331-48. [PMID: 34130334 DOI: 10.1055/s-0041-1729972] [Reference Citation Analysis]
31 Takeba Y, Ohta Y, Ootaki M, Kobayashi T, Kida K, Watanabe M, Koizumi S, Otsubo T, Iiri T, Matsumoto N. Identification of interleukin-16 production on tumor aggravation in hepatocellular carcinoma by a proteomics approach. Tumour Biol 2021;43:309-25. [PMID: 34897107 DOI: 10.3233/TUB-211507] [Reference Citation Analysis]
32 Wang X, Tian Z. γδ T cells in liver diseases. Front Med 2018;12:262-8. [DOI: 10.1007/s11684-017-0584-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
33 Liu J, Sauer MA, Hussein SG, Yang J, Tenen DG, Chai L. SALL4 and microRNA: The Role of Let-7. Genes (Basel) 2021;12:1301. [PMID: 34573282 DOI: 10.3390/genes12091301] [Reference Citation Analysis]
34 Peng H, Sun R. Liver-resident NK cells and their potential functions. Cell Mol Immunol 2017. [PMID: 28920584 DOI: 10.1038/cmi.2017.72] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
35 Walk J, Stok JE, Sauerwein RW. Can Patrolling Liver-Resident T Cells Control Human Malaria Parasite Development? Trends Immunol 2019;40:186-96. [PMID: 30713008 DOI: 10.1016/j.it.2019.01.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
36 Zongyi Y, Xiaowu L. Immunotherapy for hepatocellular carcinoma. Cancer Letters 2020;470:8-17. [DOI: 10.1016/j.canlet.2019.12.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 16.5] [Reference Citation Analysis]
37 Dash S, Aydin Y, Widmer KE, Nayak L. Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment. J Hepatocell Carcinoma 2020;7:45-76. [PMID: 32346535 DOI: 10.2147/JHC.S221187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
38 Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai CL, Voillet V, Duvvuri VR, Scherler K, Troisch P, Baloni P, Qin G, Smith B, Kornilov SA, Rostomily C, Xu A, Li J, Dong S, Rothchild A, Zhou J, Murray K, Edmark R, Hong S, Heath JE, Earls J, Zhang R, Xie J, Li S, Roper R, Jones L, Zhou Y, Rowen L, Liu R, Mackay S, O'Mahony DS, Dale CR, Wallick JA, Algren HA, Zager MA, Wei W, Price ND, Huang S, Subramanian N, Wang K, Magis AT, Hadlock JJ, Hood L, Aderem A, Bluestone JA, Lanier LL, Greenberg PD, Gottardo R, Davis MM, Goldman JD, Heath JR; ISB-Swedish COVID19 Biobanking Unit. Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell 2020;183:1479-1495.e20. [PMID: 33171100 DOI: 10.1016/j.cell.2020.10.037] [Cited by in Crossref: 85] [Cited by in F6Publishing: 91] [Article Influence: 42.5] [Reference Citation Analysis]